TKD

Takeda Pharmaceutical Company Limited

AT Healthcare Drug Manufacturers - Specialty & Generic

Latest week
10 Jul 2026
Close
28.850000
Fair value
75.257598
Next-week expectancy
Undecided 48.94%
Sharemaestro

TKD Chart Pack

Takeda Pharmaceutical Company Limited

Exchange
VIE
Latest week
10 Jul 2026
Close
28.850000
Fair value
75.257598
Next-week expectancy
Undecided 48.94%
Generated
17 Jul 2026 17:29
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, TKD rose 1.73%, moving from 28.36 to 28.85. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 32.51 and has improved across the 12-week window. Market Dynamics is 0.30 on the latest week. Next-week expectancy is undecided at 48.94% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
28.85
12-Week Change
1.73%
Trend Signal
Active
Next-Week Expectancy
Undecided 48.94%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
32.51
Market Dynamics
0.30

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
28.85
12-Week Change
1.73%
Trend Signal
Active
Next-Week Expectancy
Undecided 48.94%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
32.51
Market Dynamics
0.30

Over the latest 12 completed weeks ending 2026-07-10, TKD rose 1.73%, moving from 28.36 to 28.85. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 32.51 and has improved across the 12-week window. Market Dynamics is 0.30 on the latest week. Next-week expectancy is undecided at 48.94% based on similar historical setup states.

Industry Peers

Austria equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
ZOTS Zoetis Inc. VIE 10 Jul 2026 66.24 67.08 64.46 66.98 1.12%
KRKG Krka, d. d. VIE 10 Jul 2026 262.50 265.50 260.50 263.00 0.19%
GHC Gallmetzer HealthCare SPA VIE 10 Jul 2026 3.60 3.60 3.60 3.60 0.00%
LUNB H. Lundbeck A/S VIE 10 Jul 2026 5.76 5.85 5.69 5.69 -1.13%
ALM Almirall, S.A. VIE 10 Jul 2026 11.42 11.76 11.28 11.28 -1.23%
ROVI Laboratorios Farmaceuticos Rovi, S.A. VIE 10 Jul 2026 57.00 57.65 55.95 55.95 -1.84%
LUNA H. Lundbeck A/S VIE 10 Jul 2026 4.96 4.97 4.84 4.87 -1.92%
DMP Dermapharm Holding SE VIE 10 Jul 2026 47.65 47.65 45.65 45.75 -3.99%
TLR2 Tilray Brands, Inc. VIE 10 Jul 2026 4.07 4.10 3.72 3.90 -4.18%
MRCK Merck KGaA VIE 10 Jul 2026 146.70 146.70 138.15 140.15 -4.46%
GALD Galderma Group AG VIE 10 Jul 2026 196.00 196.00 187.00 187.00 -4.59%
TEVA Teva Pharmaceutical Industries Limited VIE 10 Jul 2026 30.40 31.10 28.60 29.00 -4.61%
EVT Evotec SE VIE 10 Jul 2026 5.17 5.19 4.85 4.92 -4.74%
IPN Ipsen S.A. VIE 10 Jul 2026 171.40 172.40 162.00 162.00 -5.48%
SDZ Sandoz Group AG VIE 10 Jul 2026 78.82 78.82 73.48 73.52 -6.72%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.